Algo version: 0.98b
Lansen Pharmaceutical is listed at the HKSE Exchange
Lansen Pharmaceutical [0503.HK]
HKSE Sector: Industry:Drug Manufacturers

Is Lansen Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Lansen Pharmaceutical pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Monday 13th of September 2021 were paid HKD1.55 per share. Over the last 19 times between 2011 and 2021, Lansen Pharmaceutical has paid HKD2.6364 with an average of HKD0.14 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Lansen Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD0.801, you would have made a profit of HKD0.989 per share or 123.33%

No, the average daily trading liquidity for Lansen Pharmaceutical is HKD476 561 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Lansen Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.14, the company's ability to pay off the debt is normal. Lansen Pharmaceutical has a good net profit margin of 11.41% and should have high tolerances against inflation.

We have calculated the inflation risk for Lansen Pharmaceutical to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.